mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |